-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, D5jLf3qhwtP97EqHyL8O1kNP+n3ZrMg+BYVKpdrlgZeh7SM5U5x860vru9OoWT2Y QGX7HweN/6+7iQg5oEqXPA== 0000930413-07-007423.txt : 20070913 0000930413-07-007423.hdr.sgml : 20070913 20070913170440 ACCESSION NUMBER: 0000930413-07-007423 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20070913 DATE AS OF CHANGE: 20070913 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Zhao Chao Ming CENTRAL INDEX KEY: 0001411869 FILING VALUES: FORM TYPE: SC 13D BUSINESS ADDRESS: BUSINESS PHONE: 865386203897 MAIL ADDRESS: STREET 1: 14 EAST HUSHAN ROAD STREET 2: TAIAN CITY CITY: SHANDONG STATE: F4 ZIP: 271000 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: China Biologic Products, Inc. CENTRAL INDEX KEY: 0001369868 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: F4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D SEC ACT: 1934 Act SEC FILE NUMBER: 005-83122 FILM NUMBER: 071115941 BUSINESS ADDRESS: STREET 1: NO.14 EAST HUSHAN ROAD CITY: TAI'AN CITY, SHANDONG STATE: F4 ZIP: 271000 BUSINESS PHONE: 86-538-620-3897 MAIL ADDRESS: STREET 1: NO.14 EAST HUSHAN ROAD CITY: TAI'AN CITY, SHANDONG STATE: F4 ZIP: 271000 FORMER COMPANY: FORMER CONFORMED NAME: GRC Holdings, Inc. DATE OF NAME CHANGE: 20060721 SC 13D 1 c50309_sc13d.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

SCHEDULE 13D
(Rule 13d-101)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULE 13d-1(a)

CHINA BIOLOGIC PRODUCTS, INC.
(Name of Issuer)

COMMON STOCK, PAR VALUE $0.0001
(Title of Class of Securities)

16938C106
(CUSIP Number)

No 14 East Hushan Road, Taian City
Shandong, China 271000
(86) 538-620-3897
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

(Date of Event which Requires Filing Statement on Schedule 13D)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box [ ].

(Continued on following pages)

NAMES OF REPORTING PERSONS

IRS IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

Chao Ming Zhao

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) [__]

(b) [__]

SEC USE ONLY

SOURCE OF FUNDS

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT

TO ITEM 2(e) or 2(f)

[__]

CITIZENSHIP OR PLACE OF ORGANIZATION

People’s Republic of China

NUMBER OF

SOLE VOTING POWER

1,071,787 shares of common stock

BENEFICIALLY

SHARED VOTING POWER

OWNED BY

EACH

SOLE DISPOSITIVE POWER

1,071,787 shares of common stock

REPORTING

PERSON WITH

10.

SHARED DISPOSITIVE POWER

11.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

1,071,787 shares of common stock

12.

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES

CERTAIN SHARES

[__]

13.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

14.

TYPE OF REPORTING PERSON

Item 1. Security and Issuer.

The name of the issuer is China Biologic Products, Inc., a Delaware corporation (the “Company”), which has its principal executive offices at No. 14 East Hushan Road, Taian City, Shandong People’s Republic of China 271000. This statement relates to the Company’s common stock, $0.0001 par value per share (the “Common Stock”).

Item 2. Identity and Background.

(a) The name of the person filing this statement is Chao Ming Zhao (“Reporting Person”).

(b) The business address of the Reporting Person is 14 East Hushan Road, Taian City, Shandong, People’s Republic of China, 10013.

(c) Mr. Zhao has been the Company’s Director since August 2006 and the Company’s Chief Financial Officer since November 2006.

(d) During the last five years, the Reporting Person has not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).

(e) During the last five years, the Reporting Person has not been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, Federal or State securities laws or finding any violation with respect to such laws.

(f) The Reporting Person is a citizen of the People’s Republic of China.

Item 3. Source and Amount of Funds or Other Consideration.

The Reporting Person received the securities covered by this statement pursuant to that certain share exchange agreement (the “Share Exchange Agreement”), dated July 19, 2006, by and between the Company, Logic Express Ltd (“Logic Express”) and the stockholders of Logic Express. Pursuant to the Share Exchange Agreement, the Company issued to the stockholders of Logic Express, 18,484,715 shares of the Common Stock in exchange for 100% of the issued and outstanding shares of capital stock of Logic Express. As a result of this reverse acquisition transaction with Logic Express, Logic Express became the Company’s 100% owned subsidiary and the equity holders of Logic Express, including the Reporting Person, became the Company’s controlling shareholders. The Reporting Person’s shares in Logic Express were obtained on July 11, 2006, as a part of his own personal investment in Logic Express.

Item 4. Purpose of Transaction.

The Reporting Person acquired the Common Stock pursuant to the Share Exchange Agreement as described in Item 3 above.

Except as set forth in this Schedule 13D and the registration statement on Form SB-2 referred to above, the Reporting Person has made no proposals, and has entered into no agreements, which would be related to or would result in any of the events or matters described in part (a) through (j) of Item 4 of Schedule 13D.

Item 5. Interest in Securities of the Issuer.

(a) As of the date of this statement, Mr. Zhao beneficially owns 1,071,787 shares of the Company’s Common Stock, representing 5% of the outstanding shares of the Company’s Common Stock. Mr. Zhao does not own any other securities of the Company.

(b) Other than the transaction in connection with the Share Exchange Agreement described in Item 3 above, the Reporting Person did not effect any transactions in the issuer’s securities within the past 60 days.

(c) Other than the Reporting Person, no other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of the Reporting Person’s securities.

(d) Not applicable.

Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.

Except as disclosed herein, there are no contracts, arrangements, understandings or relationships (legal or otherwise) among the Reporting Person and any other person with respect to any securities of the issuer, including, but not limited to transfer or voting of any of the securities, finder’s fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or loss, or the giving or withholding of proxies.

Item 7. Material to be Filed as Exhibits.

	Exhibit No.		Description

	2.1		Share Exchange Agreement between the Company, Logic Express and the
			selling stockholders signatory thereto, dated as of July 18, 2006
			[incorporated by reference to Exhibit 2 to the Company’s registration
			statement on Form SB-2 filed on September 5, 2007]

SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated:

September 13, 2007

/s/ Chao Ming Zhao

Chao Ming Zhao

-----END PRIVACY-ENHANCED MESSAGE-----